These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7536091)

  • 81. Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites.
    Chan EC; Vernon SW; Ahn C; Greisinger A
    Am J Public Health; 2004 Aug; 94(8):1336-8. PubMed ID: 15284039
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The times they are a-changin': The evolution of prostate cancer screening practices and beliefs among primary care physicians in Victoria, British Columbia.
    Spooner J; Birk M; Espinosa V; Hoag N
    Can Urol Assoc J; 2021 Jun; 15(6):192-196. PubMed ID: 33212001
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prostate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey data.
    Tchir D; Farag M; Szafron M
    Can Urol Assoc J; 2020 Jul; 14(7):E319-E327. PubMed ID: 32017690
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prostate cancer screening practices of African-American and non-African-American US primary care physicians: a cross-sectional survey.
    Richards TB; Rim SH; Hall IJ; Richardson LC; Ross LE
    Int J Gen Med; 2012; 5():775-80. PubMed ID: 23049271
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA.
    Seo HS; Lee NK
    Korean J Urol; 2010 Jun; 51(6):391-7. PubMed ID: 20577605
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey.
    Choksi P; Gay BL; Reyes-Gastelum D; Haymart MR; Papaleontiou M
    Endocr Pract; 2020 Nov; 26(11):1237-1243. PubMed ID: 33471653
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Danish General Practitioners' Use of Prostate-Specific Antigen in Opportunistic Screening for Prostate Cancer: A Survey Comprising 174 GPs.
    Jessen K; Søndergaard J; Larsen PV; Thomsen JL
    Int J Family Med; 2013; 2013():540707. PubMed ID: 24349779
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prostate cancer screening with prostate-specific antigen: A guide to the guidelines.
    Cabarkapa S; Perera M; McGrath S; Lawrentschuk N
    Prostate Int; 2016 Dec; 4(4):125-129. PubMed ID: 27995110
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Engaging the primary care community to encourage appropriate prostate cancer screening.
    Patel MP; Schulman A; Shah KP; Anderson JB; Polascik TJ
    Ther Adv Urol; 2018 Jan; 10(1):11-16. PubMed ID: 29344092
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hypertension screening in a primary care clinic.
    Hamilton AW; Birtwhistle RV
    Can Fam Physician; 1986 Jul; 32():1443-5. PubMed ID: 21267096
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Correction to: Unintended consequences of decreased PSA-based prostate cancer screening.
    Ahlering T; Huynh LM; Kaler KS; Williams S; Osann K; Joseph J; Lee D; Davis JW; Abaza R; Kaouk J; Patel V; Kim IY; Porter J; Hu JC
    World J Urol; 2020 Mar; 38(3):807. PubMed ID: 31332511
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Implications of prostate-specific antigen screening guidelines on clinical practice at a Canadian regional community hospital.
    Webster TM; Lau E; Newell KJ
    Can Urol Assoc J; 2017 Aug; 11(8):283-286. PubMed ID: 28798833
    [No Abstract]   [Full Text] [Related]  

  • 93. PSA screening: And now…a message from our experts.
    Kapoor A; Siemens DR
    Can Urol Assoc J; 2014 Nov; 8(11-12):387-8. PubMed ID: 25553144
    [No Abstract]   [Full Text] [Related]  

  • 94. Yinglu Guo: PSA screening test requires wider application in China.
    Song X
    Transl Androl Urol; 2012 Dec; 1(4):199-201. PubMed ID: 26816711
    [No Abstract]   [Full Text] [Related]  

  • 95. PSA screening: Time to overcome our brand confusion.
    Siemens DR; Gleave M
    Can Urol Assoc J; 2017 Oct; 11(10):295-296. PubMed ID: 29382439
    [No Abstract]   [Full Text] [Related]  

  • 96. PSA screening - for whom and when?
    Albers P
    Asian J Androl; 2017 Sep; 21(1):3-5. PubMed ID: 28879867
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Factors related to use of prostate cancer screening: the Alberta Tomorrow Project.
    Richardson H; Aronson KJ; James A; McGregor ES; Bryant H
    Open Med; 2007 Apr; 1(1):e3-e12. PubMed ID: 20101288
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
    Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
    J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.
    Guerra CE; Gimotty PA; Shea JA; Pagán JA; Schwartz JS; Armstrong K
    Med Decis Making; 2008; 28(5):681-9. PubMed ID: 18556635
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.